Small-cell lung cancer. Diagnostic and therapeutic recommendations of Polish Lung Cancer Group

被引:0
作者
Krzakowski, Maciej [1 ]
Orlowski, Tadeusz [2 ]
Roszkowski, Kazimierz [2 ]
Reinfuss, Marian [3 ]
Olszewski, Wlodzimierz [1 ]
Ramlau, Rodryg [4 ]
Kowalski, Dariusz [1 ]
Konopa, Krzysztof [5 ]
Jassem, Jacek [5 ]
Jankowska, Renata [6 ]
Kozielski, Jerzy [7 ]
Wojtukiewicz, Marek [8 ]
Drosik, Kazimierz [9 ]
Koralewski, Piotr [10 ]
机构
[1] Inst Warszawie, Ctr Onkol, Warsaw, Poland
[2] Inst Chorob Pluc & Gruzlicy Warszawie, Warsaw, Poland
[3] Inst Krakowie, Ctr Onkol, Krakow, Poland
[4] Wielkopolskie Ctr Chorob Pluc & Gruzlicy Poznaniu, Poznan, Poland
[5] Akad Medyczna Gdansku, Gdansk, Poland
[6] Akad Med Wroclawiu, Wroclaw, Poland
[7] Akad Med Zabrzu, Zabrze, Poland
[8] Akad Med Bialymstoku, Bialystok, Poland
[9] Wojewodzki Osrodek Onkol Opolu, Opole, Poland
[10] Wojewodzki Szpital Specjalisty Krakowie, Krakow, Poland
来源
ONCOLOGY IN CLINICAL PRACTICE | 2007年 / 3卷 / 01期
关键词
small-cell lung cancer; diagnosis; staging; recommendations; chemotherapy; radiotherapy; surgical treatment;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small-cell lung cancer is characterised by an aggressive course with high tendency for early dissemination. At presentation, patients are usually symptomatic and with hilar or mediastinal mass at radiography. Staging should be focused on identifying any evidence of distant spread. Chemotherapy including cisplatin and etoposide is a cornerstone of treatment for all patients. Limited-stage disease should be managed by chemotherapy combined with concurrent chest irradiation. All patients who achieve complete response should be considered for elective cranial irradiation. Surgical treatment may be used in highly selected patients with TNM stage I disease, and surgery should always be combined with chemotherapy. Extensive-stage disease should be managed by multi-agent chemotherapy alone. Long-term survivors should undergo careful monitoring for development of a second primary tumour.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 35 条
[1]  
Argiris A, 2001, CANCER J, V7, P437
[2]   PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
BORIE, F ;
RIVIERE, A ;
CHOMY, P ;
MONNET, I ;
TARDIVON, A ;
VIADER, F ;
TARAYRE, M ;
BENHAMOU, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :183-190
[3]   Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].
Aupérin, A ;
Arriagada, R ;
Pignon, JP ;
Le Péchoux, C ;
Gregor, A ;
Stephens, RJ ;
Kristjansen, PEG ;
Johnson, BE ;
Ueoka, H ;
Wagner, H ;
Aisner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484
[4]   Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study [J].
Baas, P ;
Belderbos, JSA ;
Senan, S ;
Kwa, HB ;
van Bochove, A ;
van Tinteren, H ;
Burgers, JA ;
van Meerbeeck, J .
BRITISH JOURNAL OF CANCER, 2006, 94 (05) :625-630
[5]   70 GY thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of cancer and leukemia group B study 39808 [J].
Bogart, JA ;
Herndon, JE ;
Lyss, AP ;
Watson, D ;
Miller, AA ;
Lee, ME ;
Turrisi, AT ;
Green, MR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :460-468
[6]   Positron emission tomography in limited-stage small-cell lung cancer: A prospective study [J].
Bradley, JD ;
Dehdashti, F ;
Mintun, MA ;
Govindan, R ;
Trinkaus, K ;
Siegel, BA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3248-3254
[7]   Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer [J].
Choi, NC ;
Herndon, JE ;
Rosenman, J ;
Carey, RW ;
Chung, CT ;
Bernard, S ;
Leone, L ;
Seagren, S ;
Green, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3528-3536
[8]   Thoracic radiotherapy for limited-stage small-cell lung cancer: Controversies and future developments [J].
Faivre-Finn, C ;
Lee, LW ;
Lorigan, P ;
West, C ;
Thatcher, N .
CLINICAL ONCOLOGY, 2005, 17 (08) :591-598
[9]   Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer [J].
Fried, DB ;
Morris, DE ;
Poole, C ;
Rosenman, JG ;
Halle, JS ;
Detterbeck, FC ;
Hensing, TA ;
Socinski, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4837-4845
[10]   Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial [J].
Gregor, A ;
Cull, A ;
Stephens, RJ ;
Kirkpatrick, JA ;
Yarnold, JR ;
Girling, DJ ;
Macbeth, FR ;
Stout, R ;
Machin, D .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1752-1758